PL367987A1 - Solid pharmaceutical formulation for a piperazine urea derivative - Google Patents
Solid pharmaceutical formulation for a piperazine urea derivativeInfo
- Publication number
- PL367987A1 PL367987A1 PL02367987A PL36798702A PL367987A1 PL 367987 A1 PL367987 A1 PL 367987A1 PL 02367987 A PL02367987 A PL 02367987A PL 36798702 A PL36798702 A PL 36798702A PL 367987 A1 PL367987 A1 PL 367987A1
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical formulation
- solid pharmaceutical
- urea derivative
- piperazine urea
- piperazine
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- QHTPSODXPLCXJB-UHFFFAOYSA-N piperazine;urea Chemical class NC(N)=O.C1CNCCN1 QHTPSODXPLCXJB-UHFFFAOYSA-N 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10152351A DE10152351B4 (de) | 2001-10-18 | 2001-10-18 | Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat |
| PCT/EP2002/011229 WO2003035037A1 (de) | 2001-10-18 | 2002-10-07 | Feste arzneimittelformulierung für ein piperazinharnstoffderivat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL367987A1 true PL367987A1 (en) | 2005-03-21 |
Family
ID=7703496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02367987A PL367987A1 (en) | 2001-10-18 | 2002-10-07 | Solid pharmaceutical formulation for a piperazine urea derivative |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1435917A1 (sr) |
| JP (1) | JP2005506365A (sr) |
| KR (1) | KR20040047920A (sr) |
| CN (1) | CN1571660A (sr) |
| AR (1) | AR037111A1 (sr) |
| AU (1) | AU2002333896B2 (sr) |
| BR (1) | BR0213340A (sr) |
| CA (1) | CA2463951A1 (sr) |
| CO (1) | CO5580740A2 (sr) |
| DE (1) | DE10152351B4 (sr) |
| EC (1) | ECSP045108A (sr) |
| HR (1) | HRP20040435A2 (sr) |
| IL (1) | IL161166A0 (sr) |
| MX (1) | MXPA04003522A (sr) |
| NO (1) | NO20042022L (sr) |
| NZ (1) | NZ532287A (sr) |
| PE (1) | PE20030472A1 (sr) |
| PL (1) | PL367987A1 (sr) |
| RS (1) | RS32204A (sr) |
| RU (1) | RU2311172C2 (sr) |
| UY (1) | UY27500A1 (sr) |
| WO (1) | WO2003035037A1 (sr) |
| ZA (1) | ZA200403781B (sr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1990469A (zh) | 2001-06-27 | 2007-07-04 | 史密丝克莱恩比彻姆公司 | 作为二肽酶抑制剂的氟代吡咯烷 |
| EP1749519A1 (de) * | 2005-08-05 | 2007-02-07 | Schering Aktiengesellschaft | Arzneiform mit Retardtierter pH-unabhängiger Wirkstofffreisetzung für Wirkstoffe mit starker pH-abhängiger Löslichkeit |
| JP5826456B2 (ja) * | 2006-04-26 | 2015-12-02 | アルファファーム ピーティーワイ リミテッド | コーティングされていない分離したユニットおよび延長放出マトリクスを含む制御放出配合物 |
| DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
| KR101654582B1 (ko) | 2016-05-12 | 2016-09-06 | 그린로드(주) | 원뿔형 부유 고분자 필터, 및 그의 제조장치 및 제조방법, 및 그를 포함하는 수처리 필터 |
| RU2729223C1 (ru) * | 2020-05-13 | 2020-08-05 | Мераб Георгиевич Чикобава | Дозированная форма для амплификации нуклеиновых кислот |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1246383B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per il mascheramento del sapore di farmaci |
| FR2668945B1 (fr) * | 1990-11-12 | 1993-02-19 | Theramex | Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus. |
| US5705190A (en) * | 1995-12-19 | 1998-01-06 | Abbott Laboratories | Controlled release formulation for poorly soluble basic drugs |
| US6004996A (en) * | 1997-02-05 | 1999-12-21 | Hoffman-La Roche Inc. | Tetrahydrolipstatin containing compositions |
| US6207665B1 (en) * | 1997-06-12 | 2001-03-27 | Schering Aktiengesellschaft | Piperazine derivatives and their use as anti-inflammatory agents |
| EA003137B1 (ru) * | 1998-02-05 | 2003-02-27 | Пфайзер Продактс Инк | Новые производные дигидроксигексановой кислоты |
| EP1027885B1 (en) * | 1999-02-09 | 2008-07-09 | Pfizer Products Inc. | Basic drug compositions with enhanced bioavailability |
-
2001
- 2001-10-18 DE DE10152351A patent/DE10152351B4/de not_active Expired - Fee Related
-
2002
- 2002-10-07 MX MXPA04003522A patent/MXPA04003522A/es unknown
- 2002-10-07 NZ NZ532287A patent/NZ532287A/en unknown
- 2002-10-07 BR BR0213340-7A patent/BR0213340A/pt not_active IP Right Cessation
- 2002-10-07 KR KR10-2004-7005591A patent/KR20040047920A/ko not_active Ceased
- 2002-10-07 PL PL02367987A patent/PL367987A1/xx not_active Application Discontinuation
- 2002-10-07 JP JP2003537604A patent/JP2005506365A/ja active Pending
- 2002-10-07 HR HR20040435A patent/HRP20040435A2/hr not_active Application Discontinuation
- 2002-10-07 IL IL16116602A patent/IL161166A0/xx unknown
- 2002-10-07 CA CA002463951A patent/CA2463951A1/en not_active Abandoned
- 2002-10-07 AU AU2002333896A patent/AU2002333896B2/en not_active Ceased
- 2002-10-07 EP EP02801884A patent/EP1435917A1/de not_active Withdrawn
- 2002-10-07 CN CNA02820512XA patent/CN1571660A/zh active Pending
- 2002-10-07 RU RU2004115328/15A patent/RU2311172C2/ru not_active IP Right Cessation
- 2002-10-07 WO PCT/EP2002/011229 patent/WO2003035037A1/de not_active Ceased
- 2002-10-07 RS YU32204A patent/RS32204A/sr unknown
- 2002-10-17 PE PE2002001027A patent/PE20030472A1/es not_active Application Discontinuation
- 2002-10-17 UY UY27500A patent/UY27500A1/es not_active Application Discontinuation
- 2002-10-18 AR ARP020103929A patent/AR037111A1/es unknown
-
2004
- 2004-05-13 CO CO04044345A patent/CO5580740A2/es not_active Application Discontinuation
- 2004-05-14 NO NO20042022A patent/NO20042022L/no not_active Application Discontinuation
- 2004-05-17 EC EC2004005108A patent/ECSP045108A/es unknown
- 2004-05-17 ZA ZA200403781A patent/ZA200403781B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04003522A (es) | 2004-07-23 |
| AU2002333896B2 (en) | 2007-07-26 |
| ECSP045108A (es) | 2004-06-28 |
| RU2004115328A (ru) | 2005-06-10 |
| PE20030472A1 (es) | 2003-06-16 |
| UY27500A1 (es) | 2003-06-30 |
| DE10152351B4 (de) | 2005-09-22 |
| KR20040047920A (ko) | 2004-06-05 |
| JP2005506365A (ja) | 2005-03-03 |
| EP1435917A1 (de) | 2004-07-14 |
| AU2002333896A2 (en) | 2003-05-06 |
| AR037111A1 (es) | 2004-10-20 |
| CA2463951A1 (en) | 2003-05-01 |
| RU2311172C2 (ru) | 2007-11-27 |
| WO2003035037A1 (de) | 2003-05-01 |
| CO5580740A2 (es) | 2005-11-30 |
| DE10152351A1 (de) | 2003-05-08 |
| NO20042022L (no) | 2004-05-14 |
| BR0213340A (pt) | 2004-10-05 |
| RS32204A (sr) | 2006-10-27 |
| CN1571660A (zh) | 2005-01-26 |
| IL161166A0 (en) | 2004-08-31 |
| HRP20040435A2 (en) | 2005-06-30 |
| ZA200403781B (en) | 2004-11-29 |
| NZ532287A (en) | 2007-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL221199A (en) | A fragrance-containing drug | |
| IL148357A0 (en) | Pharmaceutical compositions containing a benzamide derivative | |
| PL364223A1 (en) | Pharmaceutical salts | |
| IL148406A0 (en) | Pharmaceutical tramadol salts | |
| HUP0302876A3 (en) | Pharmaceutical formulation | |
| GB0118689D0 (en) | Pharmaceutical formulation | |
| PL366432A1 (en) | Pharmaceutical formulation | |
| HUP0303948A2 (hu) | Szájban diszpergálódó szilárd gyógyszerforma | |
| GB0101225D0 (en) | Pharmaceutical compounds | |
| GB0031084D0 (en) | Pharmaceutical compounds | |
| IL148169A0 (en) | Pharmaceutical compositions containing a benzamide derivative | |
| IL161166A0 (en) | Solid pharmaceutical formulation for a piperazine urea derivative | |
| GB9914255D0 (en) | Pharmaceutical compounds | |
| AU2002333896A1 (en) | Solid pharmaceutical formulation for a piperazine urea derivative | |
| GB0019272D0 (en) | Pharmaceutical compounds | |
| GB2373499B (en) | Pharmaceutical compounds | |
| GB0024318D0 (en) | Pharmaceutical compounds | |
| HK1063285A (en) | Solid pharmaceutical formulation for a piperazine urea derivative | |
| AU2002342940A8 (en) | New pharmaceutical compounds | |
| GB0005366D0 (en) | Pharmaceutical compounds | |
| HRP20040757A2 (en) | A stable pharmaceutical formulation comprising torsemide modification ii | |
| GB0014849D0 (en) | Pharmaceutical aerosol formulation | |
| GB0104749D0 (en) | Pharmaceutical formulation | |
| GB0014881D0 (en) | Pharmaceutical aerosol formulation | |
| GB0128335D0 (en) | Pharmaceutical aerosol formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |